This tumor-mediated PD-L1 expression in myeloid cells was dependent on PGE2 production, since in vitro and in vivo inhibition of PGE2 synthesis with pharmacological inhibitors markedly reduced PD-L1 by myeloid cells. The gene discussed is CD274; the disease is neoplasm.